May Orfali

Insider Reports History

Entity
Individual
Location
C/O Sigilon Therapeutics, Inc., 100 Binney Street, Suite 600, Cambridge, MA
Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by May Orfali:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sigilon Therapeutics, Inc. CHIEF MEDICAL OFFICER Stock Option (Right to Buy) 10K $7.5K $0.75 Feb 18, 2022 Direct

Insider Reports Filed by May Orfali

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGTX Sigilon Therapeutics, Inc. Feb 18, 2022 1 $14.8K 4 Feb 22, 2022 CHIEF MEDICAL OFFICER
SGTX Sigilon Therapeutics, Inc. Jan 3, 2022 1 $30.3K 4 Jan 4, 2022 CHIEF MEDICAL OFFICER
SGTX Sigilon Therapeutics, Inc. Dec 1, 2021 1 $0 4 Dec 1, 2021 CHIEF MEDICAL OFFICER
SGTX Sigilon Therapeutics, Inc. Nov 29, 2021 0 $0 3 Dec 1, 2021 CHIEF MEDICAL OFFICER